[EN] NOVEL PROTEIN KINASE INHIBITORS<br/>[FR] NOUVEAUX INHIBITEURS DE PROTÉINES KINASES
申请人:TENOVA PHARMACEUTICALS INC
公开号:WO2021216440A1
公开(公告)日:2021-10-28
The present disclosure describes novel protein kinase inhibitors and methods for preparing them. The pharmaceutical compositions comprising such protein kinase inhibitors and methods of using them for treating cancer and other diseases, conditions, or disorders, which respond to the inhibition of epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK) activity, or a combination thereof, are also described.